Venture investment in medtech and digital health has recovered since the 2008 financial crisis, but it is still difficult for medtech entrepreneurs to raise money at critical points in the capital continuum – especially moving from Seed to Series A.  Traditional VCs and strategic investors are focused on more mature medtech companies.  Early stage medtech companies are therefore forced to rely on sources (including angel groups) who may not be as well versed in and may have misconceptions about the medtech field.  This session will provide an overview of the top trends in medtech as well as the challenges early stage companies are facing as they move from concept to commercialization. Whether you are new to investing in early stage medtech companies or interested in hearing the latest industry trends, join us for networking and an informative discussion.

Register here. 


Tiffany Wilson – CEO, Global Center for Medical Innovation & T3 Labs